Announcements Trials

Browse Landscape

Phase

Phase NA 4 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Prostatic Neoplasms 8 Neoplasms 5 Lung Neoplasms 5 Head and Neck Neoplasms 5 Leukemia, Myeloid, Acute 4 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Recurrence 2 Pulmonary Disease, Chronic Obstructive 2 Neoplasm Metastasis 2 Lymphoma, Follicular 2 Leukemia 2 Colonic Neoplasms 2 COVID-19 2 Xerostomia 1 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Stroke 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1

Interventions

Doxorubicin 25 Ifosfamide 22 Radiotherapy 17 Etoposide 11 Vincristine 10 Cyclophosphamide 10 Filgrastim 8 Dactinomycin 8 Trabectedin 7 Chemotherapy, Adjuvant 5 pazopanib 4 Cisplatin 4 Topotecan 3 Radiation 3 Neoadjuvant Therapy 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Dacarbazine 3 sargramostim 2 etoposide phosphate 2 eribulin 2 Observation 2 Methotrexate 2 Mesna 2 Imatinib Mesylate 2 Gemcitabine 2 Epirubicin 2 Docetaxel 2 Dexrazoxane 2 Carboplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sarcoma × Standard of Care × Clear all

NCT04307277 2026-04-14

CHIC-STS01

Institut Claudius Regaud

Phase 3 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡